Collagen code in tumor microenvironment: Functions, molecular mechanisms, and therapeutic implications - 13/09/23
, Xin-Yang He a, f, ⁎ 
Abstract |
The tumor microenvironment (TME) is crucial in cancer progression, and the extracellular matrix (ECM) is an important TME component. Collagen is a major ECM component that contributes to tumor cell infiltration, expansion, and distant metastasis during cancer progression. Recent studies reported that collagen is deposited in the TME to form a collagen wall along which tumor cells can infiltrate and prevent drugs from working on the tumor cells. Collagen–tumor cell interaction is complex and requires the activation of multiple signaling pathways for biochemical and mechanical signaling interventions. In this review, we examine the effect of collagen deposition in the TME on tumor progression and discuss the interaction between collagen and tumor cells. This review aims to illustrate the functions and mechanisms of collagen in tumor progression in the TME and its role in tumor therapy. The findings indicated collagen in the TME appears to be a better target for cancer therapy.
Le texte complet de cet article est disponible en PDF.Graphical abstract |
Highlights |
• | Collagen is the most abundant protein in the tumor microenvironment (TME). |
• | Changes in TME homeostasis affect tumorigenesis, progression, and prognosis. |
• | Collagen affects tumor progression by regulating signaling pathways, cytokines, and immune cells in specialized TMEs. |
• | Abnormal collagen deposition in TME has a significant impact on tumor progression and prognosis. |
• | Collagen is key to tumor development and collagen-based treatment strategies are essential in antitumor therapy. |
Abbreviations : TME, ECM, COL11A1, HCC, DDR, CAFs, MMPs, α-SMA, FAPα, LOX, FAK, COL6A, FACIT, HIF, NF-κB, RTKs, CBD, GPVI, LAIR-1, OSCAR, GPR56, IAP, 2-ME, IPF, CTCs, TICs, ERK1/2, RT, PDAC, PFD, CTLA-4, PD-1, PD-L1, IFP, Treg, NK, Th2, iDC, CSFs
Keywords : Cell mechanics, Collagen, Extracellular matrix, Immunotherapy, Tumor microenvironment
Plan
Vol 166
Article 115390- octobre 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
